- Sort by Sort ascending
- Job Title Sort ascending
- Site
- Location
- Division
- Business
- Functional Area
- Date Posted
Job Title Sort ascending | Site | Location | Division | Business | Functional Area | Date Posted |
---|---|---|---|---|---|---|
AD, Access & Reimbursement- Nashville | Field Non-Sales (USA) | USA | Innovative Medicines | Market Access | Jul 17, 2024 | |
Health Policy & Public Affairs Manager | Metamorfosis | Greece | International | Innovative Medicines | Market Access | Jul 17, 2024 |
External Affairs and Solutions Manager | Barcelona Gran Vía | Spain | International | Innovative Medicines | Market Access | Jul 16, 2024 |
Associate Director, US Market Access Therapeutic Area Strategy Immunology/Neuroscience (2 positions) | East Hanover | USA | US | Innovative Medicines | Market Access | Jul 16, 2024 |
External Affairs and Solutions Manager | Barcelona Gran Vía | Spain | International | Innovative Medicines | Market Access | Jul 16, 2024 |
External Affairs and Solutions Manager | Barcelona Gran Vía | Spain | International | Innovative Medicines | Market Access | Jul 16, 2024 |
External Affairs and Solutions Manager | Barcelona Gran Vía | Spain | International | Innovative Medicines | Market Access | Jul 16, 2024 |
External Affairs and Solutions Manager | Barcelona Gran Vía | Spain | International | Innovative Medicines | Market Access | Jul 16, 2024 |
External Affairs and Solutions Manager | Barcelona Gran Vía | Spain | International | Innovative Medicines | Market Access | Jul 16, 2024 |
External Affairs and Solutions Manager | Barcelona Gran Vía | Spain | International | Innovative Medicines | Market Access | Jul 16, 2024 |
External Affairs and Solutions Manager | Barcelona Gran Vía | Spain | International | Innovative Medicines | Market Access | Jul 16, 2024 |
External Affairs and Solutions Manager | Barcelona Gran Vía | Spain | International | Innovative Medicines | Market Access | Jul 16, 2024 |
External Affairs and Solutions Manager | Barcelona Gran Vía | Spain | International | Innovative Medicines | Market Access | Jul 16, 2024 |
External Affairs and Solutions Manager | Barcelona Gran Vía | Spain | International | Innovative Medicines | Market Access | Jul 16, 2024 |
Public Sector Lead | Midrand | South Africa | International | Innovative Medicines | Market Access | Jul 15, 2024 |
Pricing, Pipeline and Life Cycle Management | Midrand | South Africa | International | Innovative Medicines | Market Access | Jul 15, 2024 |
Strategic Access and Health Economics Outcomes Research | Midrand | South Africa | International | Innovative Medicines | Market Access | Jul 15, 2024 |
Healthcare Solutions and Partnerships | Midrand | South Africa | International | Innovative Medicines | Market Access | Jul 15, 2024 |
Executive Director, Channel Strategy, Oncology & 340B - Remote | Remote Position (USA) | USA | US | Innovative Medicines | Market Access | Jul 15, 2024 |
Regional Dir, Access & Reimbursement CV California - Remote | Field Non-Sales (USA) | USA | US | Innovative Medicines | Market Access | Jul 15, 2024 |
Rare Disease Lead | Serbia | Serbia/Monten. | International | Innovative Medicines | Market Access | Jul 12, 2024 |
Patient Navigator (6:00 a.m. -3:00 p.m. MST or 9:00 a.m. - 6 p.m. EST) | East Hanover | USA | US | Innovative Medicines | Market Access | Jul 11, 2024 |
AD, Access & Reimbursement Radioligand Therapy Remote Salt Lake City | Salt Lake City, UT | USA | US | Novartis Patient Support | Market Access | Jul 10, 2024 |
Senior Patient Access Lead | Lithuania | Lithuania | International | Innovative Medicines | Market Access | Jul 09, 2024 |
Senior Public Affairs Manager (m/f/d) | Berlin West (Non-Sales Force) (Novartis Pharma GmbH) | Germany | International | Innovative Medicines | Market Access | Jul 09, 2024 |
AD, Access & Reimbursement CRM - Remote - Buffalo | Field Non-Sales (USA) | USA | US | Innovative Medicines | Market Access | Jul 09, 2024 |
Real World Evidence Research Analyst | Dublin (Novartis Corporate Center (NOCC)) | Ireland | Operations | CTS | Market Access | Jul 09, 2024 |
Solution and Service Design Assistant | London (The Westworks) | United Kingdom | International | Innovative Medicines | Market Access | Jul 05, 2024 |
NHS/Novartis Programme Lead | Field Force (England / Wales) | United Kingdom | International | Innovative Medicines | Market Access | Jul 05, 2024 |
Market Access Manager: Hospital Care Radioligandentherapien | Munich (Non-Sales Force) (Novartis Pharma GmbH) | Germany | International | Innovative Medicines | Market Access | Jul 05, 2024 |
Senior HEOR Lead | Tokyo | Japan | International | Japan IMI | Market Access | Jul 01, 2024 |
Director, Market Access Therapeutic Area Strategy - Oncology | East Hanover | USA | US | Innovative Medicines | Market Access | Jul 01, 2024 |
Regional Dir, Access & Reimbursement RLT - Remote - Central | Field Non-Sales (USA) | USA | US | Innovative Medicines | Market Access | Jun 21, 2024 |
Market Access Specialist | Hefei (Anhui Province) | China | International | Innovative Medicines | Market Access | Jun 21, 2024 |
AD, Access & Reimbursement NPS Radioligand Therapy Remote - Seattle WA | Seattle, WA | USA | US | Novartis Patient Support | Market Access | Jun 20, 2024 |
Access and HEOR Lead | Santo Amaro | Brazil | International | Innovative Medicines | Market Access | Jun 20, 2024 |
Regional Access and Solutions Manager | Bucuresti | Romania | International | Innovative Medicines | Market Access | Jun 13, 2024 |
Head, Private Payers | Field Non-Sales (Canada) | Canada | International | Innovative Medicines | Market Access | Jun 03, 2024 |
Head, Payeurs du secteur privé | Field Non-Sales (Canada) | Canada | International | Innovative Medicines | Market Access | Jun 03, 2024 |
Lead/Associate, Field Access Management | Head Office (Japan) (Pharmaceuticals) | Japan | International | Innovative Medicines | Market Access | May 30, 2024 |
Territory Account Manager | Samara | Russian Fed. | International | Innovative Medicines | Market Access | May 27, 2024 |
Real World Evidence Team Lead | Dublin (Novartis Corporate Center (NOCC)) | Ireland | Operations | CTS | Market Access | May 13, 2024 |
Healthcare partnership manager | Moscow (City) | Russian Fed. | International | Innovative Medicines | Market Access | May 13, 2024 |
New Products & Strategic Pricing Partner | Kyiv | Ukraine | International | Innovative Medicines | Market Access | Apr 16, 2024 |
Patient Access Lead | Kyiv | Ukraine | International | Innovative Medicines | Market Access | Apr 16, 2024 |
To report an adverse event or any drug related issues concerning Novartis medicinal products; please contact Novartis Patient Safety: Tel: +202 22861000 - Press 3 for reporting an adverse event.
E-mail: [email protected]
للإبلاغ عن أثر جانبى أو أي مشكلة دوائية متعلقة بمنتجات نوفارتس الطبية او الاجهزة ؛ يرجى الاتصال بقسم اليقظة الدوائية في شركة نوفارتس
+202 22861000 : الهاتف
ثم اضغط 3 للإبلاغ عن أثر جانبي +
[email protected] البريد الإلكترونى